Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

GALT Galectin Therapeutics Inc

2,14

0,04 (1,90%)

09 Aug 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
Von Jul 2024 bis Aug 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
Von Aug 2023 bis Aug 2024

Click Here for more Galectin Therapeutics Charts.

News Galectin Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 5 August 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 5 August 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 1 August 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Dienstag 23 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 23 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 20 Juni 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 15 Mai 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 März 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 7 Februar 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 7 Februar 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 7 Februar 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere Galectin Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen